Carbamazapine for Inherited Erythromelalgia Patients With NaV1.7 Mutations

计划入组 2 人 · 首次发布于 2014 年 8 月 12 日

Mechanism of Human Cold Pain Perception - Involvement of TRPA1, TRPM8, Nav1.7 and Nav1.8

计划入组 36 人 · 首次发布于 2023 年 7 月 7 日

ASO Treatment for Syndromic Craniosynostoses

计划入组 12 人 · 首次发布于 2026 年 4 月 17 日

ASO-1

NaV1.7 regulators

ASO-29

A.O.U. SAN LUIGI GONZAGA

Italy

Praxis Precision Medicines

United States

ACO

Quiver Bioscience Names Co-Founder Graham Dempsey CEO to Advance Nav1.7-Targeting ASO for Chronic Pain

Quiver Bioscience Secures $2.15M NIH Grant to Develop AI-Powered CNS Drug Safety Platform

Channel Therapeutics' NaV1.7 Inhibitor Shows Promising Results for Ocular Pain in Preclinical Trials